GFACX
Price
$65.66
Change
-$1.58 (-2.35%)
Updated
Feb 21 closing price
Net Assets
311.64B
MFEIX
Price
$204.38
Change
-$5.05 (-2.41%)
Updated
Feb 21 closing price
Net Assets
47.8B
Ad is loading...

GFACX vs MFEIX

Header iconGFACX vs MFEIX Comparison
Open Charts GFACX vs MFEIXBanner chart's image
American Funds Growth Fund of Amer C
Price$65.66
Change-$1.58 (-2.35%)
VolumeN/A
Net Assets311.64B
MFS Growth I
Price$204.38
Change-$5.05 (-2.41%)
VolumeN/A
Net Assets47.8B
GFACX vs MFEIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. MFEIX commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and MFEIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 312B vs. MFEIX (47.8B). GFACX (0.00) and MFEIX (0.00) have matching dividends . GFACX was incepted earlier than MFEIX: GFACX (24 years) vs MFEIX (28 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. MFEIX (25.00). MFEIX has a lower initial minimum investment than GFACX: MFEIX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 16.66 vs. MFEIX (12.35). MFEIX return over 5 years is better than : 53.57 vs. GFACX (37.16).
GFACXMFEIXGFACX / MFEIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years28 years-
Gain YTD6.3364.572139%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets312B47.8B653%
Annual Yield % from dividends0.000.00-
Returns for 1 year16.6612.35135%
Returns for 3 years19.7028.7169%
Returns for 5 years37.1653.5769%
Returns for 10 years61.16182.7033%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ESE169.652.62
+1.57%
ESCO Technologies
ACI20.560.03
+0.15%
Albertsons Companies
SILO1.49-0.01
-0.67%
Silo Pharma
SAMG18.78-0.24
-1.26%
Silvercrest Asset Management Group
VERV7.83-0.24
-2.97%
Verve Therapeutics